Found: 9
Select item for more details and to access through your institution.
Customer Response to Carbon Labelling of Groceries.
- Published in:
- Journal of Consumer Policy, 2011, v. 34, n. 1, p. 153, doi. 10.1007/s10603-010-9140-7
- By:
- Publication type:
- Article
Homologous Recombination Deficiency: Concepts, Definitions, and Assays.
- Published in:
- Oncologist, 2022, v. 27, n. 3, p. 167, doi. 10.1093/oncolo/oyab053
- By:
- Publication type:
- Article
BLOODPAC: Collaborating to chart a path towards blood-based screening for early cancer detection.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 1, p. 5, doi. 10.1111/cts.13427
- By:
- Publication type:
- Article
A National Assessment of Diagnostic Test Use for Patients with Advanced NSCLC and Factors Influencing Physician Decision-Making.
- Published in:
- American Health & Drug Benefits, 2020, v. 13, n. 3, p. 110
- By:
- Publication type:
- Article
Real‐world Overall Survival Using Oncology Electronic Health Record Data: Friends of Cancer Research Pilot.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 2, p. 444, doi. 10.1002/cpt.2443
- By:
- Publication type:
- Article
The C-Terminal Putative Nuclear Localization Sequence of BReast cancer Metastasis Suppressor 1, BRMS1, Is Necessary for Metastasis Suppression.
- Published in:
- PLoS ONE, 2013, v. 8, n. 2, p. 1, doi. 10.1371/journal.pone.0055966
- By:
- Publication type:
- Article
The heparanase/syndecan-1 axis in cancer: mechanisms and therapies.
- Published in:
- FEBS Journal, 2013, v. 280, n. 10, p. 2294, doi. 10.1111/febs.12168
- By:
- Publication type:
- Article
Advancing Evidence Generation for Circulating Tumor DNA: Lessons Learned from A Multi-Assay Study of Baseline Circulating Tumor DNA Levels across Cancer Types and Stages.
- Published in:
- Diagnostics (2075-4418), 2024, v. 14, n. 9, p. 912, doi. 10.3390/diagnostics14090912
- By:
- Publication type:
- Article
Tumor mutational burden standardization initiatives: Recommendations for consistent tumor mutational burden assessment in clinical samples to guide immunotherapy treatment decisions.
- Published in:
- Genes, Chromosomes & Cancer, 2019, v. 58, n. 8, p. 578, doi. 10.1002/gcc.22733
- By:
- Publication type:
- Article